ADMA Biologics Inc

ADMA Biologics develops, manufactures, and markets plasma-based immunotherapeutics—primarily immunoglobulin preparations for immunodeficient patients—and generates revenues through the sale of these prescription biologics as well as through the operation of its own plasma donation centers as a regulated raw material supplier.